Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 167

1.

Omitting radiotherapy in women ≥ 65 years with low-risk early breast cancer after breast-conserving surgery and adjuvant endocrine therapy is safe.

Wickberg Å, Liljegren G, Killander F, Lindman H, Bjöhle J, Carlberg M, Blomqvist C, Ahlgren J, Villman K.

Eur J Surg Oncol. 2018 Apr 13. pii: S0748-7983(18)31007-2. doi: 10.1016/j.ejso.2018.04.002. [Epub ahead of print]

PMID:
29709338
2.

A randomised study of tailored toxicity-based dosage of fluorouracil-epirubicin-cyclophosphamide chemotherapy for early breast cancer (SBG 2000-1).

Lindman H, Andersson M, Ahlgren J, Balslev E, Sverrisdottir A, Holmberg SB, Bengtsson NO, Jacobsen EH, Jensen AB, Hansen J, Tuxen MK, Malmberg L, Villman K, Anderson H, Ejlertsen B, Bergh J, Blomqvist C; Swedish Breast Cancer Group (SweBCG), the Danish Breast Cancer Group (DBCG) and the Scandinavian Breast Cancer Group (SBG).

Eur J Cancer. 2018 May;94:79-86. doi: 10.1016/j.ejca.2018.02.016. Epub 2018 Mar 20.

PMID:
29547834
3.

Behavioural characterization of C57BL/6N and BALB/c female mice in social home cage - Effect of mixed housing in complex environment.

Heinla I, Åhlgren J, Vasar E, Voikar V.

Physiol Behav. 2018 May 1;188:32-41. doi: 10.1016/j.physbeh.2018.01.024. Epub 2018 Jan 31.

4.

Behaviour of freshwater snails (Radix balthica) exposed to the pharmaceutical sertraline under simulated predation risk.

Hedgespeth ML, Karasek T, Ahlgren J, Berglund O, Brönmark C.

Ecotoxicology. 2018 Mar;27(2):144-153. doi: 10.1007/s10646-017-1880-6. Epub 2018 Jan 18.

5.

20-Year Risks of Breast-Cancer Recurrence after Stopping Endocrine Therapy at 5 Years.

Pan H, Gray R, Braybrooke J, Davies C, Taylor C, McGale P, Peto R, Pritchard KI, Bergh J, Dowsett M, Hayes DF; EBCTCG.

N Engl J Med. 2017 Nov 9;377(19):1836-1846. doi: 10.1056/NEJMoa1701830.

6.

Feasibility of a self-help web-based intervention targeting young cancer patients with sexual problems and fertility distress.

Wiklander M, Strandquist J, Obol CM, Eriksson LE, Winterling J, Rodriguez-Wallberg KA, Sjögren Fugl-Meyer K, Ahlgren J, Ljungman P, Lampic C, Wettergren L.

Support Care Cancer. 2017 Dec;25(12):3675-3682. doi: 10.1007/s00520-017-3793-6. Epub 2017 Jul 18.

7.

Survival and axillary recurrence following sentinel node-positive breast cancer without completion axillary lymph node dissection: the randomized controlled SENOMAC trial.

de Boniface J, Frisell J, Andersson Y, Bergkvist L, Ahlgren J, Rydén L, Olofsson Bagge R, Sund M, Johansson H, Lundstedt D; SENOMAC Trialists’ Group.

BMC Cancer. 2017 May 26;17(1):379. doi: 10.1186/s12885-017-3361-y.

8.

Oncologists and hematologists' perceptions of fertility-related communication - a nationwide survey.

Micaux Obol C, Armuand GM, Rodriguez-Wallberg KA, Ahlgren J, Ljungman P, Wettergren L, Lampic C.

Acta Oncol. 2017 Aug;56(8):1103-1110. doi: 10.1080/0284186X.2017.1310394. Epub 2017 Apr 5.

PMID:
28379723
9.

Adjuvant Capecitabine in Combination With Docetaxel, Epirubicin, and Cyclophosphamide for Early Breast Cancer: The Randomized Clinical FinXX Trial.

Joensuu H, Kellokumpu-Lehtinen PL, Huovinen R, Jukkola-Vuorinen A, Tanner M, Kokko R, Ahlgren J, Auvinen P, Lahdenperä O, Kosonen S, Villman K, Nyandoto P, Nilsson G, Poikonen-Saksela P, Kataja V, Junnila J, Bono P, Lindman H.

JAMA Oncol. 2017 Jun 1;3(6):793-800. doi: 10.1001/jamaoncol.2016.6120.

10.

A validation of DCIS registration in a population-based breast cancer quality register and a study of treatment and prognosis for DCIS during 20 years.

Wadsten C, Heyman H, Holmqvist M, Ahlgren J, Lambe M, Sund M, Wärnberg F.

Acta Oncol. 2016 Nov;55(11):1338-1343. Epub 2016 Aug 22.

PMID:
27548561
11.

Effect of selective serotonin reuptake inhibitors use on endocrine therapy adherence and breast cancer mortality: a population-based study.

Valachis A, Garmo H, Weinman J, Fredriksson I, Ahlgren J, Sund M, Holmberg L.

Breast Cancer Res Treat. 2016 Sep;159(2):293-303. doi: 10.1007/s10549-016-3928-3. Epub 2016 Aug 5.

12.

Heritability of hypothyroidism in the Finnish Hovawart population.

Åhlgren J, Uimari P.

Acta Vet Scand. 2016 Jun 7;58(1):39. doi: 10.1186/s13028-016-0221-8.

13.

Aromatase inhibitors alone or sequentially combined with tamoxifen in postmenopausal early breast cancer compared with tamoxifen or placebo - Meta-analyses on efficacy and adverse events based on randomized clinical trials.

Rydén L, Heibert Arnlind M, Vitols S, Höistad M, Ahlgren J.

Breast. 2016 Apr;26:106-14. doi: 10.1016/j.breast.2016.01.006. Epub 2016 Feb 18. Review.

PMID:
27017249
14.

Adjuvant denosumab in breast cancer (ABCSG-18): a multicentre, randomised, double-blind, placebo-controlled trial.

Gnant M, Pfeiler G, Dubsky PC, Hubalek M, Greil R, Jakesz R, Wette V, Balic M, Haslbauer F, Melbinger E, Bjelic-Radisic V, Artner-Matuschek S, Fitzal F, Marth C, Sevelda P, Mlineritsch B, Steger GG, Manfreda D, Exner R, Egle D, Bergh J, Kainberger F, Talbot S, Warner D, Fesl C, Singer CF; Austrian Breast and Colorectal Cancer Study Group.

Lancet. 2015 Aug 1;386(9992):433-43. doi: 10.1016/S0140-6736(15)60995-3. Epub 2015 May 31.

PMID:
26040499
15.

Individual boldness is linked to protective shell shape in aquatic snails.

Ahlgren J, Chapman BB, Nilsson PA, Brönmark C.

Biol Lett. 2015 Apr;11(4):20150029. doi: 10.1098/rsbl.2015.0029.

16.

A stepped care stress management intervention on cancer-related traumatic stress symptoms among breast cancer patients—a randomized study in group vs. individual setting.

Rissanen R, Nordin K, Ahlgren J, Arving C.

Psychooncology. 2015 Sep;24(9):1028-35. doi: 10.1002/pon.3763. Epub 2015 Jan 28.

PMID:
25631707
17.

Sickness absence and disability pension following breast cancer - A population-based matched cohort study.

Lundh MH, Lampic C, Nordin K, Ahlgren J, Bergkvist L, Lambe M, Berglund A, Johansson B.

Breast. 2014 Dec;23(6):844-51. doi: 10.1016/j.breast.2014.09.007. Epub 2014 Oct 11.

PMID:
25305791
18.

O-MAX chemotherapy: high activity in metastatic esophagogastric adenocarcinoma and possible relation to subclinical hemolysis.

Ahlgren J, Patel N, Simmens S, Akin E, Bishop C, Kirkel D, Siegel P, Schuck S, Guebre-Xabiher H, Siegel R.

Oncology. 2014;87(6):371-80. doi: 10.1159/000366425. Epub 2014 Sep 13.

PMID:
25227924
19.

Group versus individual stress management intervention in breast cancer patients for fatigue and emotional reactivity: a randomised intervention study.

Rissanen R, Arving C, Ahlgren J, Nordin K.

Acta Oncol. 2014 Sep;53(9):1221-9. doi: 10.3109/0284186X.2014.923935. Epub 2014 Jul 9.

PMID:
25007225
20.

Birth size in the most recent pregnancy and maternal mortality in premenopausal breast cancer by tumor characteristics.

Hajiebrahimi M, Cnattingius S, Lambe M, Hsieh CC, Ahlgren J, Adolfsson J, Bahmanyar S.

Breast Cancer Res Treat. 2014 Jun;145(2):471-80. doi: 10.1007/s10549-014-2956-0. Epub 2014 Apr 18.

PMID:
24744092

Supplemental Content

Loading ...
Support Center